These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16263140)

  • 21. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial cells differentially express functional CXC-chemokine receptor-4 (CXCR-4/fusin) under the control of autocrine activity and exogenous cytokines.
    Feil C; Augustin HG
    Biochem Biophys Res Commun; 1998 Jun; 247(1):38-45. PubMed ID: 9636650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
    Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
    Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.
    Salcedo R; Oppenheim JJ
    Microcirculation; 2003 Jun; 10(3-4):359-70. PubMed ID: 12851652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
    Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
    Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
    Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential adhesion of prostate cancer cells to bone is mediated by binding to bone marrow endothelial cells as compared to extracellular matrix components in vitro.
    Cooper CR; McLean L; Walsh M; Taylor J; Hayasaka S; Bhatia J; Pienta KJ
    Clin Cancer Res; 2000 Dec; 6(12):4839-47. PubMed ID: 11156243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chemokine network in cancer--much more than directing cell movement.
    Kulbe H; Levinson NR; Balkwill F; Wilson JL
    Int J Dev Biol; 2004; 48(5-6):489-96. PubMed ID: 15349823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and activation of alpha v beta 3 integrins by SDF-1/CXC12 increases the aggressiveness of prostate cancer cells.
    Sun YX; Fang M; Wang J; Cooper CR; Pienta KJ; Taichman RS
    Prostate; 2007 Jan; 67(1):61-73. PubMed ID: 17034033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
    Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
    Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
    Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
    Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
    Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
    Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Trentin L; Miorin M; Facco M; Baesso I; Carraro S; Cabrelle A; Maschio N; Bortoli M; Binotto G; Piazza F; Adami F; Zambello R; Agostini C; Semenzato G
    Br J Haematol; 2007 Sep; 138(5):594-602. PubMed ID: 17686053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.
    Shen H; Schuster R; Lu B; Waltz SE; Lentsch AB
    Prostate; 2006 Dec; 66(16):1721-8. PubMed ID: 16941672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage.
    Cristino S; Piacentini A; Manferdini C; Codeluppi K; Grassi F; Facchini A; Lisignoli G
    Tissue Eng Part A; 2008 Jan; 14(1):97-105. PubMed ID: 18333808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activated eosinophils upregulate the metastasis suppressor molecule E-cadherin on prostate tumor cells.
    Furbert-Harris PM; Parish-Gause D; Hunter KA; Vaughn TR; Howland C; Okomo-Awich J; Forrest K; Laniyan I; Abdelnaby A; Oredipe OA
    Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1009-16. PubMed ID: 14682382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors.
    Gijsbers K; Gouwy M; Struyf S; Wuyts A; Proost P; Opdenakker G; Penninckx F; Ectors N; Geboes K; Van Damme J
    Exp Cell Res; 2005 Feb; 303(2):331-42. PubMed ID: 15652347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
    Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
    Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR3-binding chemokines in multiple myeloma.
    Pellegrino A; Antonaci F; Russo F; Merchionne F; Ribatti D; Vacca A; Dammacco F
    Cancer Lett; 2004 Apr; 207(2):221-7. PubMed ID: 15072832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
    Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Prieto JC; Carmena MJ
    Prostate; 2009 May; 69(7):774-86. PubMed ID: 19189304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.